Scalper1 News
AstraZeneca (AZN) early Monday rejected a raised takeover bid from Pfizer (PFE), which Pfizer called its “final proposal” to the British drug giant. AstraZeneca stock tumbled 10% in morning trading on the stock market today, while Pfizer stock was up 1.3%. Late Sunday, Pfizer issued a press release saying that it had bid 55 pounds — about $92.50 — a share for AstraZeneca, for a total of $117 billion. The bid was not only about 15% higher than Scalper1 News
Scalper1 News